Vimarsana
Biggest News Aggregation in the World

Moderated Poster Session News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Moderated Poster Session. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Moderated Poster Session Today - Breaking & Trending Today

ABIVAX ABSTRACT ON OBEFAZIMOD PHASE 2B RESULTS SELECTED FOR MODERATED POSTER PRESENTATION AT UEG WEE - Vimarsana News

ABIVAX ABSTRACT ON OBEFAZIMOD PHASE 2B RESULTS SELECTED FOR MODERATED POSTER PRESENTATION AT UEG WEE

Published: September 27, 2022

EQS-News: ABIVAX / Key word(s): MiscellaneousABIVAX ABSTRACT ON OBEFAZIMOD PHASE 2B RESULTS SELECTED FOR MODERATED POSTER PRESENTATION AT UEG WEEK 2022 27.09.2022 / 18:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Abivax abstract on obefazimod phase 2b results selected for moderate...

Source: pharmiweb.com
Related Topics:
Region FlamandeFrance GeneralSeverine VermeireEnregistrement UniverselGastroenterol HepatolUniversity Hospitals LeuvenDistribution ServicesEuronext ParisUnited European GastroenterologyScience LoungeVirtual PosterInflammatory Bowel DiseasesModerated Poster SessionLancet GastroenterologyMayo ScoreReview BoardTruffle CapitalAlthough AbivaxFrench AutoritDes MarchImpact FactorCitation ReportsLancet Gastroenterol HepatolCorporate NewsRegulatory Announcements
Cytokinetics Announces Results From Cohort 3 of Redwood-HCM - Vimarsana News

Cytokinetics Announces Results From Cohort 3 of Redwood-HCM

Published: April 2, 2022

Aficamten Reduced LVOT Gradients and Improved NYHA Class and NT-proBNP in Patients with Obstructive Hypertrophic Cardiomyopathy Treated with Disopyramide...

Source: globenewswire.com
Related Topics:
Joanna SiegallFadyi MalikAnjalit OwensAmerican College Of CardiologyResearch DevelopmentExchange CommissionCytokinetics Incorporated NasdaqUs Food Drug AdministrationCorporate CommunicationsNational Medical Products AdministrationUniversity Of PennsylvaniaRandomized EvaluationDosing WithObstructive Outflow DiseaseModerated Poster SessionMedical DirectorInherited Cardiac DiseaseAssistant ProfessorAmerican CollegeAnnual Scientific SessionCytokinetic Executive Vice PresidentBreakthrough Therapy DesignationDrug AdministrationPrivate Securities Litigation Reform ActSafe Harbor
Cytokinetics Announces Results From Cohort 3 of Redwood-HCM Presented at American College of Cardiology 71st Annual Scientific Session - Press Release - Vimarsana News

Cytokinetics Announces Results From Cohort 3 of Redwood-HCM Presented at American College of Cardiology 71st Annual Scientific Session - Press Release

Published: April 2, 2022

SOUTH SAN FRANCISCO, Calif., April 02, 2022 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated CYTK today announced that the full results from Cohort 3 of

Source: wiredprnews.com
Related Topics:
Joanna SiegallFadyi MalikAnjalit OwensCytokinetics IncorporatedAmerican College Of CardiologyResearch DevelopmentExchange CommissionUs Food Drug AdministrationCorporate CommunicationsNational Medical Products AdministrationUniversity Of PennsylvaniaRandomized EvaluationDosing WithObstructive Outflow DiseaseModerated Poster SessionMedical DirectorInherited Cardiac DiseaseAssistant ProfessorAmerican CollegeAnnual Scientific SessionCytokinetic Executive Vice PresidentBreakthrough Therapy DesignationDrug AdministrationPrivate Securities Litigation Reform ActSafe Harbor